arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

ROCKWELL MEDICAL, INC.

RMTI
$7.26 ▼ -0.01 (-0.14%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
67 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
32
Health
Poor
Bearish
auto_awesome

Analytical Summary

ROCKWELL MEDICAL, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $286.2M
Dividend Yield
Revenue Growth -8.3%
Op. Margin -8.5%
ROIC -2.7%
FCF / Share $-0.00
Trailing P/E
Price / Book 8.0x
FCF Yield
Debt / Equity 0.23
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$17.34M
↓ -8.3%
Net Income Profit after all expenses
$-1.60M
↓ -5.9%
Operating Margin Operating profit as % of sales
-8.5%
↑ +14.2% 18th
FCF / Share Free cash flow per share
$-0.00
↑ +95.9%
Long-Term Debt Long-term obligations
$8.21M
↓ -7.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
20
Returns
31
Financial Health
52
Cash Quality
27

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters